p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma
被引:1
|
作者:
Li, Pei-Hua
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Li, Pei-Hua
[1
]
Cao, Wen-Jia
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Cao, Wen-Jia
[3
]
Mao, Lin-Lin
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Mao, Lin-Lin
[3
]
Huang, Hui
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Huang, Hui
[3
]
Zheng, Jun-Nian
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Affiliated Hosp, Ctr Clin Oncol, Xuzhou 221002, Peoples R China
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Zheng, Jun-Nian
[2
,3
]
Pei, Dong-Sheng
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
Pei, Dong-Sheng
[3
]
机构:
[1] Xuzhou Med Coll, Affiliated Hosp, Dept Otorhinolaryngol, Xuzhou 221002, Peoples R China
[2] Xuzhou Med Coll, Affiliated Hosp, Ctr Clin Oncol, Xuzhou 221002, Peoples R China
[3] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China
p42.3 is a tumor-specific gene and found to be over-expressed in many tumor cell lines and primary tumor tissues. It plays a significant role in neoplastic transformation and tumor progression. To date, the association between p42.3 and Renal-Cell Carcinoma (RCC) has not been reported. This study investigated the biological effects and mechanisms of p42.3 in RCC progression. In this study, we found that p42.3 is overexpressed in various kinds of RCC cells, and knockdown of p42.3 dramatically reduced cell proliferation and invasion in vitro. Our studies revealed that overexpression of p42.3 accelerates the epithelial-mesenchymal transition (EMT) progression and induces RCC cells proliferation and invasion. Further studies show that p42.3 may involve in activation of beta-catenin and participate in RCC cell invasion. Combined, these data indicate that p42.3 contributes to promoting RCC cells proliferation and invasion through accelerates the EMT progression and beta-catenin activation.
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Shandong Acad Med Sci, Affiliated Hosp, Jinan, Peoples R ChinaXuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Cao, Wen-Jia
Du, Wen-Qi
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R ChinaXuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Du, Wen-Qi
Mao, Lin-Lin
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R ChinaXuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Mao, Lin-Lin
Zheng, Jun-Nian
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Peoples R China
Xuzhou Med Coll, Affiliated Hosp, Ctr Clin Oncol, Xuzhou 221002, Peoples R ChinaXuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Zheng, Jun-Nian
Pei, Dong-Sheng
论文数: 0引用数: 0
h-index: 0
机构:
Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Peoples R China
Xuzhou Med Coll, Dept Pathol, 209 Tong Shan Rd, Xuzhou, Jiangsu, Peoples R ChinaXuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Peoples R China
机构:
Laboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/InstituteLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute
Wei Sun
Wei-Wei Dong
论文数: 0引用数: 0
h-index: 0
机构:
Department of Medical Oncology,The General Hospital of Chinese People's Liberation ArmyLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute
Wei-Wei Dong
Lin-Lin Mao
论文数: 0引用数: 0
h-index: 0
机构:
Jiangsu Key Laboratory of Biological Cancer Therapy,Xuzhou Medical CollegeLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute
Lin-Lin Mao
论文数: 引用数:
h-index:
机构:
Wen-Mei Li
Jian-Tao Cui
论文数: 0引用数: 0
h-index: 0
机构:
Laboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/InstituteLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute
Jian-Tao Cui
Rui Xing
论文数: 0引用数: 0
h-index: 0
机构:
Laboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/InstituteLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute
Rui Xing
You-Yong Lu
论文数: 0引用数: 0
h-index: 0
机构:
Laboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/InstituteLaboratory of Molecular Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital/Institute